Back
Kratos Defense & Security Solutions, Inc. 10K Form
Buy
68
KTOS
Kratos Defense & Security Solutions, Inc.
Last Price:
$89.10
Seasonality Move:
-0.48%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive KTOS News And Ratings
See the #1 stock for the next 7 days that we like better than KTOS
KTOS Financial Statistics
Sales & Book Value
| Annual Sales: | $1.3B |
|---|---|
| Cash Flow: | $-12.1M |
| Price / Cash Flow: | 503.82 |
| Annual Sales: | $11.82 |
| Price / Book: | 8.32 |
Profitability
| EPS (TTM): | 0.13160 |
|---|---|
| Net Income (TTM): | $22M |
| Gross Margin: | $298.3M |
| Return on Equity: | 1.27% |
| Return on Assets: | 0.96% |
Kratos Defense & Security Solutions, Inc. Earnings Forecast
Key Kratos Defense & Security Solutions, Inc. Financial Ratios
-
The Gross Profit Margin over the past 29 years for KTOS is 22.15%.
-
The Selling, General & Administrative Expenses for KTOS have been equal to 17.83% of Gross Profit Margin.
-
The Research & Development expenses have been 2.97% of Revenue.
-
The Interest Expense is 47.73% of Operating Income.
-
The Net Earning history of KTOS is 1.63% of Total Revenues.
-
Per Share Earnings over the last 29 years have been positive in 16 years.
Kratos Defense & Security Solutions, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Aerospace & Defense |
| Sector: | Industrials |
| Current Symbol: | KTOS |
| CUSIP: | 50077B |
| Website: | kratosdefense.com |
Debt
| Debt-to-Equity Ratio: | 0.07 |
|---|---|
| Current Ratio: | 4.06 |
| Quick Ratio: | 3.28 |
Price-to-Earnings
| Trailing P/E Ratio: | 667.79 |
|---|---|
| Forward P/E Ratio: | 83.04 |
KTOS Technical Analysis vs Fundamental Analysis
Buy
68
Kratos Defense & Security Solutions, Inc. (KTOS)
is a Buy
Is Kratos Defense & Security Solutions, Inc. a Buy or a Sell?
-
Kratos Defense & Security Solutions, Inc. stock is rated a BuyThe current Kratos Defense & Security Solutions, Inc. [KTOS] share price is $88.95. The Score for KTOS is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.